Private Advisor Group’s Mangoceuticals MGRX Stock Holding History

Private Advisor Group’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-680	Closed	-$8.68K	–	2407
2023 Q3	$8.68K	Buy	+680	New	+$12.7K	﹤0.01%	2183

Other funds holding MGRX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

Vanguard Capital Wealth Advisors Denver, Colorado $148M AUM 91.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Private Advisor Group's MGRX Position: Q4 2023 in Review

Private Advisor Group sold out of Mangoceuticals (MGRX) in Q4 2023, closing a stake of 680 shares — an estimated $8.68K sold.

Private Advisor Group first reported a position in MGRX in Q3 2023 and held it in 1 quarter. The position peaked at $8.68K in Q3 2023. 5 funds tracked by Wall St. Rank hold MGRX as of Q4 2023.

Private Advisor Group reported no remaining Mangoceuticals position as of Q4 2023 after selling out during the quarter.
Private Advisor Group sold 680 Mangoceuticals shares in Q4 2023, an estimated $8.68K.
Private Advisor Group first reported a position in Mangoceuticals in Q3 2023 and held it in 1 quarter.
Private Advisor Group's Mangoceuticals position peaked at $8.68K in Q3 2023.
5 funds tracked by Wall St. Rank held Mangoceuticals as of Q4 2023.

Based on Private Advisor Group's 13F filing for Q4 2023, filed 6 Feb 2024.